Table 1

Patient characteristics

CharacteristicStudy eye (n=11)Fellow eye (n=11)
Age (years)72±5
GenderMale6 (55)
Female5 (45)
Glaucoma stage*Early8 (73)11 (100)
Moderate2 (18)
Severe1 (9)
Sensor in the right eye8 (73)3 (27)
BCVA (ETDRS letter score)83 (79, 86)82±4
MD (dB)−3 (−6, –1)−2±2
VFI (dB)95 (90, 99)97 (92, 99)
PSD (dB)2.5 (1.5–6.5)2.0 (1.7–3.9)
CCT (µm)568±49566±44
Glaucoma surgeries†09 (82)9 (82)
11 (9)2 (18)
21 (9)
Glaucoma medications‡04 (36)3 (27)
11 (9)2 (18)
23 (27)3 (27)
33 (27)3 (27)
  • Normal distributed continuous data presented as mean±SD, non-normal distributed data presented as median (IQR) and counts presented as number (%).

  • *One female patient of 77 years was staged with severe glaucoma in the study eye (BCVA=58, MD=−21.46 and PSD=13.23 dB, left eye). Two patients were staged with moderate glaucoma in the study eye, one male of 78 years (BCVA=88, MD=−10.29, PSD=8.81, left eye) and one female of 76 years (BCVA=86, MD=−6.98, PSD=6.4, right eye). The other eight patients were staged with mild glaucoma in the study eye.

  • †One patient had previously undergone selective laser treatment in the study eye. Another patient had trabeculectomy and selective laser trabeculoplasty in the study eye. The filtering bleb in the latter patient was not functional (being flat and scarred), and pressure-lowering medication was necessary at the time.

  • ‡Four patients did not use medication at the time of experiments. Lack of compliance was the main reason for not using antiglaucomatous medication in two patients. In two other patients, IOP stabilised within an acceptable range without medication after cataract surgery with implantation of the Eyemate IOP sensor.

  • BCVA, best-corrected visual acuity (using ETDRS letters); CCT, central corneal thickness; MD, mean defect in visual field; PSD, visual field—pattern SD; VFI, visual field index (Humphrey Field Analyzer III).